Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
Chris DickhoffSuresh SenanFamke L SchneidersJoris VeltmanSayed HashemiJohannes M A DanielsMarieke FransenDavid J HeinemanTeodora RadonicPeter M van de VenImke H BartelinkLilian J MeijboomJuan J Garcia-VallejoDaniela E Oprea-LagerTanja D de GruijlIdris BahcePublished in: BMC cancer (2020)
Netherlands Trial Registration (NTR): NL8435 , Registered 03 March 2020.